This further supports our experimental evidence demonstrating a role for FBW7 in B-cell lymphomagenesis through regulation of BCL6 ubiquitination and stability, suggesting that FBW7/BCL6 could be a potential target in DLBCL therapy. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.